Ciphergen Biosystems, Inc. Files for Initial Public Offering.Business Editors/Health and Medical Writers PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif.--(BW HealthWire)--March 21, 2000 Ciphergen Biosystems, Inc. announced today that it has filed with the Securities and Exchange Commission a registration statement relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the proposed initial public offering of its Common Stock. All of the shares will be sold by Ciphergen Biosystems. The public offering is being managed by an underwriting group led by SG Cowen, and ING Barings and Warburg Dillon Read Investment bank created by the 1997 merger of S.G. Warburg & Co. and Dillon, Read & Co. Subsequently renamed UBS Warburg and now part of UBS AG, where the Warburg name was eventually dropped. LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control are co-managers of the offering. A preliminary prospectus Preliminary Prospectus A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders , when available, relating to these securities may be obtained from SG Cowen Securities Corporation, Financial Square, 28th Floor, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10005-3597, Attn: Prospectus Department. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state. About Ciphergen Biosystems, Inc. Ciphergen Biosystems develops, manufactures, markets a proprietary ProteinChip(R) System that enables protein discovery, characterization and assay development that provides better understanding of biological function at the protein level. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion